Related Experiment Video

Updated: Sep 20, 2025

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

1.1K

Potential future biologic therapies for the treatment of vitiligo: focus on phase 2 and 3

Vincenzo Picone1, Luigi Coronella1, Massimiliano Scalvenzi1

  • 1Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Expert Review of Clinical Immunology
|May 26, 2025
PubMed
Abstract

Insights

New vitiligo treatments targeting immune responses show promise. Emerging therapies like JAK inhibitors and monoclonal antibodies offer hope for improved patient outcomes in this chronic autoimmune skin condition.

Area of Science:

  • Dermatology
  • Immunology
  • Genetics

Background:

  • Vitiligo is a chronic autoimmune skin disorder causing melanocyte loss and depigmentation.
  • It significantly impacts patients' quality of life, necessitating advanced therapeutic strategies.

Purpose of the Study:

  • To review recent advancements in vitiligo pathogenesis.
  • To evaluate novel therapeutic approaches based on clinical trial data.

Main Methods:

  • Literature search focusing on genetic predisposition, environmental triggers, and immune dysregulation (CD8+ T cells, IFN-γ).
  • Analysis of recent clinical trials and emerging therapies, including JAK inhibitors and monoclonal antibodies.

Main Results:

  • Emerging therapies like JAK inhibitors (povorcitinib, upadacitinib) and monoclonal antibodies (anifrolumab) show potential.
  • Efficacy and safety data from Phase II and III clinical trials are being evaluated.

Conclusions:

  • Targeted therapies addressing immune mechanisms and oxidative stress are promising for vitiligo management.
  • These novel approaches may significantly improve patient outcomes in the near future.
Keywords:
JakVitiligobiologicsmonoclonal antibodiestargeted therapy

More Related Videos

Direct Reprogramming of Mouse Fibroblasts into Melanocytes09:38

Direct Reprogramming of Mouse Fibroblasts into Melanocytes

Published on: August 27, 2021

2.2K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.6K

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.3K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.3K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
523
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
677
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
384